Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine (Q35997398)

11 August 2017

Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine (English)

1 reference

11 August 2017

4

Shelly A McNeil

1 reference

11 August 2017

1

Myron J Levin

1 reference

11 August 2017

Kenneth E Schmader

2

1 reference

11 August 2017

John W Gnann

3

1 reference

11 August 2017

Timo Vesikari

5

1 reference

11 August 2017

Robert F Betts

6

1 reference

11 August 2017

Susan Keay

7

1 reference

11 August 2017

Jon E Stek

8

1 reference

11 August 2017

Nickoya D Bundick

9

1 reference

11 August 2017

Shu-Chih Su

10

1 reference

11 August 2017

Yanli Zhao

11

1 reference

11 August 2017

Xiaoming Li

12

1 reference

11 August 2017

Ivan S F Chan

13

1 reference

11 August 2017

Paula W Annunziato

14

1 reference

11 August 2017

Janie Parrino

15

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

Journal of Infectious Diseases

11 August 2017

1 reference

11 August 2017

208

1 reference

11 August 2017

9

1 reference

11 August 2017

1386-1390

1 reference

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Zoster vaccine: current status and future prospects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Racial differences in the occurrence of herpes zoster

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Cellular and Humoral Immunity in the Pathogenesis of Recurrent Herpes Viral Infections in Patients with Lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Immune response to a refrigerator-stable zoster vaccine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

A community-based survey of varicella-zoster virus-specific immune responses in the elderly.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of age.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4550114

Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23908486

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIT342

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

23908486

1 reference